Victory Medical Center Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Dental practices that purchase or compound glutathione as an adjunctive therapy (e.g., for oral mucositis, oxidative stress, or adjunct to whitening) should verify their inventory against the recalled lots to avoid potential pyrogenic reactions in patients.
Key points
- Recall covers specific lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials distributed nationwide from Victory Medical Center Pharmacy (Austin, TX) with elevated bacterial endotoxin levels.
- Product recalled to the patient level after internal testing detected endotoxin above acceptable limits; FDA notified August 5, 2026.
- Clinics using glutathione in IV or topical protocols for oral surgery, oncology, or cosmetic dentistry should quarantine affected stock and contact the pharmacy for lot verification.
- No adverse events reported yet, but elevated endotoxins pose risk of fever or inflammatory responses, especially in immunocompromised dental patients.
Who should care
Read the original on FDA Recalls
Full reporting and any paywall content live on fda.gov. We summarize and score; we do not republish.
Related
- ·Business
Why the dental assistant shortage could get worse
- ·Business
US Oral Surgery Management exec on M&A: ‘We’ve had to be even more disciplined’
- ·Research
Vertical dimension of occlusion restoration using a digital injectable composite resin technique: A 5-year clinical follow-up
- ·Research
A digitally guided workflow integrating tooth preparation and restoration positioning for minimally invasive veneer and partial-coverage restorations: A dental technique